INSERM (Institut National de la Sante et de la Recherche Medicale);Universite Paris Descartes
发明人:
Alain Tedgui,Xavier Loyer,Pierre-Emmanuel Rautou
申请号:
US14390918
公开号:
US09193971B2
申请日:
2013.04.10
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.